Article Details
Retrieved on: 2021-08-12 19:29:03
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... fast-track designation to VTX-801, a gene therapy developed by clinical-stage biotechnology company Vivet Therapeutics in conjunction with Pfizer, ...
Article found on: www.biopharminternational.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here